Alzheimer’s (BMS)

Enrolling Now
Study Information

A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease

Apply to Participate

If you are interested in participating in this study, please complete the following preliminary qualification form.

We will follow-up with you after we have received your submission.

"*" indicates required fields

General Information

Name*
ZIP / Postal Code*

Preferences

Email Opt-In*
SMS/Text Opt-In*
This field is for validation purposes and should be left unchanged.